tucatinib prolongs survival in breast cancer with brain mets - medpage today
Published 3 years ago • 131 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
1:44
'massive improvement' with second-line enhertu in her2 breast cancer - medpage today
-
3:15
a close look at tucatinib in her breast cancer
-
1:30
tucatinib in her2 breast cancer with leptomeningeal metastases
-
2:01
her2climb: tucatinib in combination w/ capecitabine & trastuzumab
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
7:38
tucatinib plus trastuzumab & capecitabine for patients with her2-positive breast cancer & brain mets
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
3:13
mona's story: battling advanced breast cancer
-
24:38
stage 4 matastatic her 2 positive breast cancer third line enhertu and fourth line of treatment
-
2:08
recent progress in managing brain metastasis in breast cancer
-
3:15
brain metastases in her2 breast cancer
-
1:20
dr. ahmed on remaining questions with tucatinib in breast cancer brain metastases
-
2:15
dr. hamilton on the promise of tucatinib in her2 breast cancer brain metastases
-
0:48
dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
-
1:16
her2climb-04: tucatinib plus t-dxd for her2 breast cancer
-
2:00
survival advantage observed in her2 breast cancer with brain metastasis
-
0:38
treatment updates for breast cancer with brain metastases
-
1:52
dr. o’shaughnessy on the utility of tucatinib in the her2 breast cancer brain metastases
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer